Lamb, Harriet M.; Goa, Karen L. - In: Disease Management and Health Outcomes 5 (1999) 2, pp. 101-115
, with possibly fewer gastrointestinal and CNS tolerability problems than imipenem/cilastatin. Therefore, meropenem is likely …Neutropenic patients with cancer are at risk of serious infection, particularly if neutropenia is severe or prolonged … infection. Prompt empirical antibacterial therapy is imperative in neutropenic patients with fever, as minor localised …